Trials / Sponsors / TrippBio, Inc.
TrippBio, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) Relative Bioavailability | Phase 1 | 2024-09-01 |
| Completed | An Evaluation of the Effect of Food on the PK of a Novel PanCytoVir™ Suspension (100mg/ml), in Healthy, Adult Relative Bioavailability | Phase 1 | 2024-09-01 |
| Completed | A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 I COVID-19 | Phase 2 | 2022-07-12 |